Dashenlin Pharm Grp Co Ltd Market Cap ($3.58 Billion)
Market Cap & Net Worth: Dashenlin Pharm Grp Co Ltd (603233)
Dashenlin Pharm Grp Co Ltd market cap. Dashenlin Pharm Grp Co Ltd (SHG:603233) has a market capitalization of $3.58 Billion (CN¥24.47 Billion) as of November 8, 2026. Listed on the SHG stock exchange, this China-based company holds position #4274 globally and #618 in its home market, demonstrating a 16.67% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Dashenlin Pharm Grp Co Ltd's stock price CN¥21.49 by its total outstanding shares 1138854520 (1.14 Billion). Also see 603233 cash flow metrics for how efficiently the company converts equity into cash flow.
Dashenlin Pharm Grp Co Ltd Market Cap History (2017–2026)
Dashenlin Pharm Grp Co Ltd market cap history from 2017 to 2026. Data shows growth from $2.93 Billion to $3.58 Billion (6.38% CAGR). Check 603233 share price today for real-time trading data and today's change.
Dashenlin Pharm Grp Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Dashenlin Pharm Grp Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 603233 net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.11x
Dashenlin Pharm Grp Co Ltd's market cap is 0.11 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.38x
Dashenlin Pharm Grp Co Ltd's market cap is 2.38 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $2.93 Billion | $7.42 Billion | $474.96 Million | 0.39x | 6.17x |
| 2018 | $2.28 Billion | $8.86 Billion | $531.63 Million | 0.26x | 4.29x |
| 2019 | $3.94 Billion | $11.14 Billion | $702.66 Million | 0.35x | 5.61x |
| 2020 | $7.15 Billion | $14.58 Billion | $1.06 Billion | 0.49x | 6.73x |
| 2021 | $4.68 Billion | $16.76 Billion | $791.23 Million | 0.28x | 5.91x |
| 2022 | $5.37 Billion | $21.25 Billion | $1.04 Billion | 0.25x | 5.19x |
| 2023 | $4.15 Billion | $24.53 Billion | $1.17 Billion | 0.17x | 3.56x |
| 2024 | $2.51 Billion | $26.50 Billion | $914.75 Million | 0.09x | 2.74x |
| 2025 | $2.94 Billion | $27.50 Billion | $1.24 Billion | 0.11x | 2.38x |
Competitor Companies of 603233 by Market Capitalization
Companies near Dashenlin Pharm Grp Co Ltd in the global market cap rankings as of November 8, 2026. Also see 603233 total asset value for a full breakdown of the balance sheet.
Key companies related to Dashenlin Pharm Grp Co Ltd by market ranking:
- JD HEALTH INTL LTD (F:8ZN): Ranked #1887 globally with a market cap of $12.04 Billion USD ( €10.30 Billion EUR).
- Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #2107 globally with a market cap of $10.37 Billion USD.
- Clicks (JSE:CLS): Ranked #5006 globally with a market cap of $2.73 Billion USD ( ZAC5.14 Trillion ZAC).
- ALIB.HL.INF.TEC.UNSP.ADR (F:TWYA): Ranked #2446 globally with a market cap of $8.42 Billion USD ( €7.20 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1887 | JD HEALTH INTL LTD | F:8ZN | $12.04 Billion | €4.87 |
| #2107 | Walgreens Boots Alliance Inc | NASDAQ:WBA | $10.37 Billion | $11.98 |
| #5006 | Clicks | JSE:CLS | $2.73 Billion | ZAC22000.00 |
| #2446 | ALIB.HL.INF.TEC.UNSP.ADR | F:TWYA | $8.42 Billion | €8.95 |
Market Capitalization of Dashenlin Pharm Grp Co Ltd (2017–2026)
Market capitalization of Dashenlin Pharm Grp Co Ltd from 2017 to today. Between 2017 and today, Dashenlin Pharm Grp Co Ltd's market cap moved from $2.93 Billion to $ 3.58 Billion, with a yearly change of 6.38%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥3.58 Billion | +21.96% |
| 2025 | CN¥2.94 Billion | +17.00% |
| 2024 | CN¥2.51 Billion | -39.52% |
| 2023 | CN¥4.15 Billion | -22.79% |
| 2022 | CN¥5.37 Billion | +14.90% |
| 2021 | CN¥4.68 Billion | -34.58% |
| 2020 | CN¥7.15 Billion | +81.41% |
| 2019 | CN¥3.94 Billion | +72.75% |
| 2018 | CN¥2.28 Billion | -22.10% |
| 2017 | CN¥2.93 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 8th, 2026 the market cap of Dashenlin Pharm Grp Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.58 Billion USD |
| MoneyControl | $3.58 Billion USD |
| MarketWatch | $3.58 Billion USD |
| marketcap.company | $3.58 Billion USD |
| Reuters | $3.58 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Dashenlin Pharm Grp Co Ltd
DaShenLin Pharmaceutical Group Co., Ltd. engages in the manufacture, distribution, and retail of pharmaceutical products in China. It offers Chinese and Western patent medicines, ginseng and tonic herbs, Chinese herbal medicine slices, health products, medical devices, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China.